Home » Topics » BioWorld Science

BioWorld Science
RSS

Circuit, synuclein insights reported in Parkinson's disease

June 10, 2022

Novel humanized mouse model of rheumatoid arthritis

June 10, 2022

Circulating miRNAs associated with difficult-to-treat RA

June 10, 2022

Washington University extends research of Hoth's HT-ALZ in mouse model of Alzheimer's disease

June 10, 2022

New in vitro data support advancing SLS-004 for dementia with Lewy bodies

June 10, 2022

Adropin as novel therapeutic target to attenuate fibroblast activation and fibrosis in SSc

June 10, 2022

Exscientia describes MALT1 inhibitors

June 10, 2022

Lundbeck divulges catecholamine prodrugs for Parkinson's disease

June 10, 2022

New SERD inducers disclosed for treatment of cancer

June 10, 2022

Gilead Sciences describes GLP-1 receptor agonists

June 10, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...